Cutaquig is a Subcutaneous Solution in the Plasma Derivative category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Human Immunoglobulin G.
| Product ID | 0069-1476_0f26c79f-3d04-7c5c-d75d-bff9405f4dff |
| NDC | 0069-1476 |
| Product Type | Plasma Derivative |
| Proprietary Name | Cutaquig |
| Generic Name | Immunoglobulin G |
| Dosage Form | Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2019-09-13 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125668 |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Substance Name | HUMAN IMMUNOGLOBULIN G |
| Active Ingredient Strength | 165 mg/mL |
| Pharm Classes | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2019-09-13 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA125668 |
| Product Type | LOT DISTRIBUTION DATA |
| Billing Unit | ML |
| Marketing Start Date | 2019-09-13 |
| Marketing Category | BLA |
| Application Number | BLA125668 |
| Product Type | LOT DISTRIBUTION DATA |
| Billing Unit | ML |
| Marketing Start Date | 2019-09-13 |
| Ingredient | Strength |
|---|---|
| HUMAN IMMUNOGLOBULIN G | 165 mg/mL |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0069-1061 | Cutaquig | immunoglobulin G |
| 0069-1476 | Cutaquig | immunoglobulin G |
| 0069-1509 | Cutaquig | immunoglobulin G |
| 0069-1802 | Cutaquig | immunoglobulin G |
| 0069-1960 | Cutaquig | immunoglobulin G |
| 0069-1965 | Cutaquig | immunoglobulin G |
| 68982-810 | Cutaquig | immunoglobulin G |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() CUTAQUIG 87225330 5880441 Live/Registered |
Octapharma AG 2016-11-03 |